Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid
Philippines·Neoasia(s) Pte Ltd. - 6 Tagore Dr. #04-07 Tagore Building Singapore, 787623 Mfd. By: Bioxis Pharmaceuticals SAS - 317 Avenue Jean Jaures Lyon 69007 France For: Rose Pharma S.A. - Via San Gottardo, 10 - 6900 Lugano - Switzerland·Singapore·Issued June 24, 2025 – June 24, 2030- Product Name
- Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid
- Registration Number
- CMDR-2025-04691
- Country of Origin
- Singapore
- Importer/Distributor
- Metro Drug, Inc.
- Issuance Date
- June 24, 2025
- Expiry Date
- June 24, 2030
Access comprehensive regulatory information for Volution Aliaxin® SV Superior Volume Cross-Linked Hyaluronic Acid in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2025-04691 and manufactured by Neoasia(s) Pte Ltd. - 6 Tagore Dr. #04-07 Tagore Building Singapore, 787623 Mfd. By: Bioxis Pharmaceuticals SAS - 317 Avenue Jean Jaures Lyon 69007 France For: Rose Pharma S.A. - Via San Gottardo, 10 - 6900 Lugano - Switzerland in Singapore. The device was registered on June 24, 2025.
This page provides complete registration details including manufacturer information, importer/distributor details (Metro Drug, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.